miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma
Open Access
- 31 March 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Biomedical Science
- Vol. 18 (1), 24
- https://doi.org/10.1186/1423-0127-18-24
Abstract
Background Artemin (ARTN) is a neurotrophic factor belonging to the glial cell-derived neurotrophic factor family of ligands. To develop potential therapy targeting ARTN, we studied the roles of miR-223 in the migration and invasion of human esophageal carcinoma. Methods ARTN expression levels were detected in esophageal carcinoma cell lines KYSE-150, KYSE-510, EC-9706, TE13, esophageal cancer tissues and paired non-cancerous tissues by Western blot. Artemin siRNA expression vectors were constructed to knockdown of artemin expression mitigated migration and invasiveness in KYSE150 cells. Monolayer wound healing assay and Transwell invasion assay were applied to observe cancer cell migration and invasion. The relative levels of expression were quantified by real-time quantitative PCR. Results ARTN expression levels were higher in esophageal carcinoma tissue than in the adjacent tissue and was differentially expressed in various esophageal carcinoma cell lines. ARTN mRNA contains a binding site for miR-223 in the 3'UTR. Co-transfection of a mir-223 expression vector with pMIR-ARTN led to the reduced activity of luciferase in a dual-luciferase reporter gene assay, suggesting that ARTN is a target gene of miR-223. Overexpression of miR-223 decreased expression of ARTN in KYSE150 cells while silencing miR-223 increased expression of ARTN in EC9706 cells. Furthermore, overexpression of miR-223 in KYSE150 cells decreased cell migration and invasion. Silencing of miR-223 in EC9706 cells increased cell migration and invasiveness. Conclusions These results reveal that ARTN, a known tumor metastasis-related gene, is a direct target of miR-223 and that miR-223 may have a tumor suppressor function in esophageal carcinoma and could be used in anticancer therapies.Keywords
This publication has 23 references indexed in Scilit:
- Nerve Growth Factor and Artemin Are Paracrine Mediators of Pancreatic Neuropathy in Pancreatic AdenocarcinomaAnnals of Surgery, 2010
- Artemin Stimulates Oncogenicity and Invasiveness of Human Endometrial Carcinoma CellsEndocrinology, 2010
- Artemin is oncogenic for human mammary carcinoma cellsOncogene, 2009
- The Structure of the Glial Cell Line-derived Neurotrophic Factor-Coreceptor Complex: INSIGHTS INTO RET SIGNALING AND HEPARIN BINDINGPublished by Elsevier BV ,2008
- The Neurotrophic Factor Artemin Promotes Pancreatic Cancer InvasionAnnals of Surgery, 2006
- Expression of glial cell line–derived neurotrophic factor family members and their receptors in pancreatic cancersSurgery, 2005
- Genome-Wide Copy Number Imbalances Identified in Familial and Sporadic Medullary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2003
- Human Glial Cell Line-derived Neurotrophic Factor Receptor α4 Is the Receptor for Persephin and Is Predominantly Expressed in Normal and Malignant Thyroid Medullary CellsPublished by Elsevier BV ,2001
- GFRα3 is an orphan member of the GDNF/neurturin/persephin receptor familyProceedings of the National Academy of Sciences of the United States of America, 1998
- Identification and Characterization of GFRα-3, a Novel Co-receptor Belonging to the Glial Cell Line-derived Neurotrophic Receptor FamilyPublished by Elsevier BV ,1998